세계의 후각 상실증 시장 보고서(2025년)

Anosmia is a medical condition characterized by either a complete or partial loss of the sense of smell. This condition can arise from various factors affecting the olfactory system, such as nasal congestion, nasal polyps, neurological disorders, head injuries, viral infections, or exposure to certain chemicals or medications. Anosmia can be either temporary or permanent and may affect one or both nostrils. It typically diminishes the ability to detect or identify odors, which can impact the sense of taste and overall quality of life.

Anosmia is primarily categorized into idiopathic anosmia and congenital anosmia. Idiopathic anosmia denotes a loss of smell with no identifiable cause, even after extensive medical evaluation and diagnostic testing. Treatments for anosmia may include therapies and medications, with several healthcare providers, including hospitals and clinics, being involved in the management of the condition.

The anosmia market research report is one of a series of new reports from The Business Research Company that provides anosmia market statistics, including the anosmia industry global market size, regional shares, competitors with anosmia market share, detailed anosmia market segments, market trends, and opportunities, and any further data you may need to thrive in the anosmia industry. These anosmia market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anosmia market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $3.9 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to growing incidence of anosmia cases, increasing number of anosmia cases, rising research grants and research activities for drug development for anosmia, increasing demand for healthcare, and research activities for drug development for anosmia.

The anosmia market size is expected to see strong growth in the next few years. It will grow to $5.65 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increase in funding from private and government organizations, development of pharmaceutical manufacturing segments, rise in R&D activities for drugs, and rise in therapeutics for anosmia acts. Major trends in the forecast period include technological advancements, advanced treatment for anosmia, increase in funding from private and government organizations, and development of advanced pharmaceutical manufacturing.

The increasing prevalence of neurological disorders is expected to drive the growth of the anosmia market in the coming years. Neurological disorders refer to a wide range of conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. The rise in these disorders is primarily due to an aging population and the growing incidence of chronic diseases like diabetes and hypertension. These conditions can lead to anosmia by damaging the olfactory pathways or areas of the brain responsible for processing smells, resulting in the loss of the ability to detect or perceive odors. For example, in March 2023, the Alzheimer's Association, a US-based nonprofit health organization, reported that 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections suggesting this number could reach 13.8 million by 2060. Therefore, the growing incidence of neurological disorders is fueling the expansion of the anosmia market.

Key players in the anosmia market are concentrating on creating innovative solutions, such as smell training kits, to offer effective and non-invasive treatments for individuals experiencing loss of smell. These kits are designed to help users improve or recover their sense of smell, particularly after losing it due to causes such as viral infections or head injuries. For instance, in March 2022, Gousto, a meal kit provider based in the UK, introduced the Flavor Savior smell training kits. These kits aim to help individuals who have lost their sense of smell and taste due to anosmia by stimulating their smell receptors and aiding in the recovery of these senses.

In November 2023, the UK-based charity Fifth Sense collaborated with ENT UK to enhance the care for individuals with smell and taste disorders. This partnership is focused on supporting both patients and healthcare providers dealing with conditions such as anosmia. ENT UK is a professional membership organization representing the field of ear, nose, and throat surgery in the UK.

Major companies operating in the anosmia market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb and Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lily and Company, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma Limited, Cipla Inc., Alphapharm Pty. Ltd., Alde Medi Impex Ltd.

North America was the largest region in the anosmia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the anosmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anosmia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anosmia market consists of revenues earned by entities by providing services such as olfactory testing and imaging, medical consultations, therapeutic services, medication management, rehabilitative services including psychological support and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The anosmia market also includes sales of diagnostic tools, medical devices, and nasal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anosmia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anosmia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anosmia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anosmia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Idiopathic Anosmia; Congenital Anosmia
• 2) By Treatment: Therapies; Medications
• 3) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Idiopathic Anosmia: Partial Idiopathic Anosmia; Complete Idiopathic Anosmia
• 2) By Congenital Anosmia: Isolated Congenital Anosmia; Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anosmia Market Characteristics

3. Anosmia Market Trends And Strategies

4. Anosmia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Anosmia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anosmia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anosmia Market Growth Rate Analysis
• 5.4. Global Anosmia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anosmia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anosmia Total Addressable Market (TAM)

6. Anosmia Market Segmentation

• 6.1. Global Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Anosmia
• Congenital Anosmia
• 6.2. Global Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapies
• Medications
• 6.3. Global Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.4. Global Anosmia Market, Sub-Segmentation Of Idiopathic Anosmia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Partial Idiopathic Anosmia
• Complete Idiopathic Anosmia
• 6.5. Global Anosmia Market, Sub-Segmentation Of Congenital Anosmia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolated Congenital Anosmia
• Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)

7. Anosmia Market Regional And Country Analysis

• 7.1. Global Anosmia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anosmia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anosmia Market

• 8.1. Asia-Pacific Anosmia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anosmia Market

• 9.1. China Anosmia Market Overview
• 9.2. China Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anosmia Market

• 10.1. India Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anosmia Market

• 11.1. Japan Anosmia Market Overview
• 11.2. Japan Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anosmia Market

• 12.1. Australia Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anosmia Market

• 13.1. Indonesia Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anosmia Market

• 14.1. South Korea Anosmia Market Overview
• 14.2. South Korea Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anosmia Market

• 15.1. Western Europe Anosmia Market Overview
• 15.2. Western Europe Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anosmia Market

• 16.1. UK Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anosmia Market

• 17.1. Germany Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anosmia Market

• 18.1. France Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anosmia Market

• 19.1. Italy Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anosmia Market

• 20.1. Spain Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anosmia Market

• 21.1. Eastern Europe Anosmia Market Overview
• 21.2. Eastern Europe Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anosmia Market

• 22.1. Russia Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anosmia Market

• 23.1. North America Anosmia Market Overview
• 23.2. North America Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anosmia Market

• 24.1. USA Anosmia Market Overview
• 24.2. USA Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anosmia Market

• 25.1. Canada Anosmia Market Overview
• 25.2. Canada Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anosmia Market

• 26.1. South America Anosmia Market Overview
• 26.2. South America Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anosmia Market

• 27.1. Brazil Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anosmia Market

• 28.1. Middle East Anosmia Market Overview
• 28.2. Middle East Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anosmia Market

• 29.1. Africa Anosmia Market Overview
• 29.2. Africa Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anosmia Market Competitive Landscape And Company Profiles

• 30.1. Anosmia Market Competitive Landscape
• 30.2. Anosmia Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anosmia Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb and Company
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. GlaxoSmithKline PLC
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lily and Company
• 31.10. Gilead Sciences Inc.
• 31.11. Viatris Inc.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Regeneron Pharmaceuticals Inc.
• 31.14. Biogen Inc.
• 31.15. Astellas Pharma Inc.

32. Global Anosmia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anosmia Market

34. Recent Developments In The Anosmia Market

35. Anosmia Market High Potential Countries, Segments and Strategies

• 35.1 Anosmia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anosmia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anosmia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer